You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Genetic Assay for Inhibitors of RNA-Protein Interactions

    SBC: ADVANCED GENETIC SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): RNA-protein interactions play critical roles in cellular regulatory processes and in the life cycles of many pathogenic viruses, including HIV, hepatitis C, and West Nile virus, and thus represent attractive targets for therapeutics. Much of our previous work has centered on identifying and characterizing the components of key interactions and developing cell-b ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  2. Peptide Transduction-based Therapies for CF

    SBC: Ansata Therapeutics, Inc.            Topic: N/A

    DESCRIPTION: (provided by applicant): Cystic fibrosis (CF) is a genetic disease caused by mutations in the gene encoding CFTR that results in a significantly shorter lifespan as well as associated pathologies. Unfortunately, none of the currently available treatments are able to halt the progression of the disease. The predominant CFTR mutation, deltaF508, results in a mutant protein that is retai ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  3. Anti Inflammatory Membranes for Implantable Biosensors

    SBC: APPLIED TISSUE AND MATERIALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The prolonged inflammatory response to an implant is one of the primary causes for the failure to integrate implanted devices into tissue. The source of inflammation common to almost all implants is the foreign body response. Based on evidence in the literature and from our research team, the inflammatory response is mediated by the reactive oxygen species gene ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  4. Light Visor for Treating Jet Lag: Controlled Field Trial

    SBC: Bio-Brite, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Jet lag is a syndrome of behavioral, cognitive, and physical symptoms that result when travelers are exposed to a sudden shift of the day-night cycle. These symptoms impact on alertness and performance of airline and military personnel and the safety of the traveling public. They may also exacerbate medical and psychiatric illness, and frequent flyers may face ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  5. Imaging & Localizing Device Using the Barkhausen Effect

    SBC: Biomed Innovations, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): This application proposes a new method for imaging medical devices that can contain amorphous ferromagnetic materials. Potential devices include Fiducial markers, surgical clips, catheters, and brachytherapy-seeds. The procedure would not require radioactive materials and would be relatively insensitive to inhomogeneities. Small array- or stereologic-detecto ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  6. Automated RNA Isolation and RT-PCR for Cancer Detection

    SBC: CEPHEID            Topic: N/A

    DESCRIPTION (provided by applicant): Cepheid develops integrated sample preparation and detection systems for rapid molecular diagnostic applications at a point of use environment. Currently, Cepheid has the GeneXpert system, which is a cartridge and instrument platform for integrated sample preparation and real-time PCR detection of target nucleic acids in biological samples. The current config ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  7. DISTANCE LEARNING SYSTEM FOR LOW VISION REHABILITATION

    SBC: Emerald Events, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of the proposed STTR project is to develop an online distance learning system and online courses to teach low vision rehabilitation to occupational therapists, vision rehabilitation teachers, ophthalmic and optometric technicians, nurse educators, and nursing home and assisted living center staff. Recent changes in Medicare coverage policies have ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  8. Lung Delivery of Nebulized Tissue Plasminogen Activator

    SBC: HTD Biosystems Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Acute respiratory distress syndrome (ARDS) afflicts tens of thousands of individuals annually in the United States and is associated with significant mortality. Presently, there is no effective treatment and little optimism exists for prospective therapies currently under investigation. A unique antiinflammatory agent (protein) that reduces neutrophil reactive ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  9. Parallel Assays for Anti-Ro Peptide Diagnostics

    SBC: JK AUTOIMMUNITY, INC.            Topic: N/A

    DESCRIPTION (provided by the applicant): Diagnosis of rheumatic diseases is inefficient, time consuming, and frustrating. Indeed, many patients suffer unnecessarily. We wish to develop a parallel assay system for the serology of autoimmune rheumatic diseases involving multiple analytes (on the order of 1,500 per assay performed) by concentrating upon the anti-Ro autoantibody system. Anti-Ro is as ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  10. Rational Development of Thyroid Receptor Antagonists

    SBC: MOLSOFT, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Molsoft proposes to develop antagonist lead molecules against the thyroid hormone receptor (TR) with IC50s in the low nanoM range and favorable bioavailability, specificity, and toxicity profiles. Proof of concept was achieved in Phase I Molsoft's virtual ligand screening technology allowed the discovery of 14 small molecule TR antagonists displaying extreme s ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government